Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
which is an anticancer drug candidate currently in clinical trials
Smiles: CC(=O)NC1C=CC(=CC=1)S(=O)(=O)NC1C=CC(=CC=1)[N+]([O-])=O
InChiKey: KEHNCEDHZGQSNP-DQSJHHFOSA-N
and synaptic vesicle recycling
β-Interleukin II (44-56) Size:Contact [email protected] for quotation which is an anticancer drugInterleukin II (44 56), (C68H113N19O19) is a peptide with the sequence NH2 ILE LEU ASN GLY ILE ASN ASN TYR LYS ASN PRO LYS LEU COOH, MW= 1500. 7. Interleukin 2 (IL 2) belongs to the interleukin family, a type of cytokine signaling molecule in the immune system, and it is a protein that regulates the activities of the white blood cells (leukocytes, often lymphocytes) responsible for immunity. IL 2, a soluble hormone like mediator of the immune system,
US$ 79.92
US$ 600.00
US$ 143.32
US$ 50.09
US$ 207.00
US$ 68.99
US$ 83.99
US$ 23.62